ROS, Editorial Office. 2021. “The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited”. Reactive Oxygen Species 11 (February):n7–n8. https://doi.org/10.20455/ros.2021.n.807.